Novo Nordisk Aims for the Top: CagriSema Poised for Breakthrough US$ 22.88 Min. order: 1 piece ★★★★★ 4.7 (12 reviews) Sold : Login>>
Novo Nordisk advances obesity candidate to late-stage program after weight loss of less than 12% US$ 23.78 Min. order: 1 piece ★★★★★ 4.1 (172 reviews) Sold : Login>>
Novo Nordisk's cagrilintide shows promise in Phase 3 trial | Alan Nafiev posted on the topic US$ 20.52 Min. order: 1 piece ★★★★★ 4.9 (22 reviews) Sold : Login>>
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product' – NBC Connecticut US$ 20.10 Min. order: 1 piece ★★★★★ 4.6 (134 reviews) Sold : Login>>